 | • レポートコード：QYR9ST05030 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、鎌状赤血球病治療の世界市場について調査・分析し、鎌状赤血球病治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（予防接種及び抗生物質による感染予防、輸血、薬物ヒドロキシカルバミド、骨髄細胞移植）、用途別（病院、外来手術センター、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の鎌状赤血球病治療市場動向 ・主要企業別マーケットシェア ・鎌状赤血球病治療の種類別市場規模2014-2019 （予防接種及び抗生物質による感染予防、輸血、薬物ヒドロキシカルバミド、骨髄細胞移植） ・鎌状赤血球病治療の用途別市場規模2014-2019 （病院、外来手術センター、クリニック、その他） ・鎌状赤血球病治療の北米市場：主要企業・種類別/用途別市場規模 ・鎌状赤血球病治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・鎌状赤血球病治療の中国市場：主要企業・種類別/用途別市場規模 ・鎌状赤血球病治療の日本国内市場：主要企業・種類別/用途別市場規模 ・鎌状赤血球病治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・鎌状赤血球病治療のインド市場：主要企業・種類別/用途別市場規模 ・鎌状赤血球病治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca、Eli Lilly、Bristol-Myers Squibb、Novartis、Pfizer、Baxter、Emmaus Life Sciences、Bluebird Bio、Global Blood Therapeutics、Sangamo Therapeutics、Acceleron Pharma、Arena Pharmaceuticals、Alnylam Pharmaceuticals） ・鎌状赤血球病治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person’s parents.The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication.
In 2018, the global Sickle Cell Disease Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Sickle Cell Disease Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle Cell Disease Treatments development in United States, Europe and China.
The key players covered in this study
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird Bio
Global Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Market segment by Type, the product can be split into
Infection Prevention with Vaccination and Antibiotics
Blood Transfusion
The Medication Hydroxycarbamide
A Transplant of Bone Marrow Cells
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Sickle Cell Disease Treatments status, future forecast, growth opportunity, key market and key players.
To present the Sickle Cell Disease Treatments development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Sickle Cell Disease Treatments are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (2014-2025)
1.4.2 Infection Prevention with Vaccination and Antibiotics
1.4.3 Blood Transfusion
1.4.4 The Medication Hydroxycarbamide
1.4.5 A Transplant of Bone Marrow Cells
1.5 Market by Application
1.5.1 Global Sickle Cell Disease Treatments Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Sickle Cell Disease Treatments Market Size
2.2 Sickle Cell Disease Treatments Growth Trends by Regions
2.2.1 Sickle Cell Disease Treatments Market Size by Regions (2014-2025)
2.2.2 Sickle Cell Disease Treatments Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Sickle Cell Disease Treatments Market Size by Manufacturers
3.1.1 Global Sickle Cell Disease Treatments Revenue by Manufacturers (2014-2019)
3.1.2 Global Sickle Cell Disease Treatments Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sickle Cell Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.2 Sickle Cell Disease Treatments Key Players Head office and Area Served
3.3 Key Players Sickle Cell Disease Treatments Product/Solution/Service
3.4 Date of Enter into Sickle Cell Disease Treatments Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Sickle Cell Disease Treatments Market Size by Type (2014-2019)
4.2 Global Sickle Cell Disease Treatments Market Size by Application (2014-2019)
5 United States
5.1 United States Sickle Cell Disease Treatments Market Size (2014-2019)
5.2 Sickle Cell Disease Treatments Key Players in United States
5.3 United States Sickle Cell Disease Treatments Market Size by Type
5.4 United States Sickle Cell Disease Treatments Market Size by Application
6 Europe
6.1 Europe Sickle Cell Disease Treatments Market Size (2014-2019)
6.2 Sickle Cell Disease Treatments Key Players in Europe
6.3 Europe Sickle Cell Disease Treatments Market Size by Type
6.4 Europe Sickle Cell Disease Treatments Market Size by Application
7 China
7.1 China Sickle Cell Disease Treatments Market Size (2014-2019)
7.2 Sickle Cell Disease Treatments Key Players in China
7.3 China Sickle Cell Disease Treatments Market Size by Type
7.4 China Sickle Cell Disease Treatments Market Size by Application
8 Japan
8.1 Japan Sickle Cell Disease Treatments Market Size (2014-2019)
8.2 Sickle Cell Disease Treatments Key Players in Japan
8.3 Japan Sickle Cell Disease Treatments Market Size by Type
8.4 Japan Sickle Cell Disease Treatments Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Sickle Cell Disease Treatments Market Size (2014-2019)
9.2 Sickle Cell Disease Treatments Key Players in Southeast Asia
9.3 Southeast Asia Sickle Cell Disease Treatments Market Size by Type
9.4 Southeast Asia Sickle Cell Disease Treatments Market Size by Application
10 India
10.1 India Sickle Cell Disease Treatments Market Size (2014-2019)
10.2 Sickle Cell Disease Treatments Key Players in India
10.3 India Sickle Cell Disease Treatments Market Size by Type
10.4 India Sickle Cell Disease Treatments Market Size by Application
11 Central & South America
11.1 Central & South America Sickle Cell Disease Treatments Market Size (2014-2019)
11.2 Sickle Cell Disease Treatments Key Players in Central & South America
11.3 Central & South America Sickle Cell Disease Treatments Market Size by Type
11.4 Central & South America Sickle Cell Disease Treatments Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sickle Cell Disease Treatments Introduction
12.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sickle Cell Disease Treatments Introduction
12.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sickle Cell Disease Treatments Introduction
12.3.4 Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sickle Cell Disease Treatments Introduction
12.4.4 Novartis Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sickle Cell Disease Treatments Introduction
12.5.4 Pfizer Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Baxter
12.6.1 Baxter Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sickle Cell Disease Treatments Introduction
12.6.4 Baxter Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.6.5 Baxter Recent Development
12.7 Emmaus Life Sciences
12.7.1 Emmaus Life Sciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sickle Cell Disease Treatments Introduction
12.7.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.7.5 Emmaus Life Sciences Recent Development
12.8 Bluebird Bio
12.8.1 Bluebird Bio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sickle Cell Disease Treatments Introduction
12.8.4 Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.8.5 Bluebird Bio Recent Development
12.9 Global Blood Therapeutics
12.9.1 Global Blood Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sickle Cell Disease Treatments Introduction
12.9.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.9.5 Global Blood Therapeutics Recent Development
12.10 Sangamo Therapeutics
12.10.1 Sangamo Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sickle Cell Disease Treatments Introduction
12.10.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2014-2019)
12.10.5 Sangamo Therapeutics Recent Development
12.11 Acceleron Pharma
12.12 Arena Pharmaceuticals
12.13 Alnylam Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Sickle Cell Disease Treatments Key Market Segments
Table Key Players Sickle Cell Disease Treatments Covered
Table Global Sickle Cell Disease Treatments Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sickle Cell Disease Treatments Market Size Market Share by Type 2014-2025
Figure Infection Prevention with Vaccination and Antibiotics Figures
Table Key Players of Infection Prevention with Vaccination and Antibiotics
Figure Blood Transfusion Figures
Table Key Players of Blood Transfusion
Figure The Medication Hydroxycarbamide Figures
Table Key Players of The Medication Hydroxycarbamide
Figure A Transplant of Bone Marrow Cells Figures
Table Key Players of A Transplant of Bone Marrow Cells
Table Global Sickle Cell Disease Treatments Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Sickle Cell Disease Treatments Report Years Considered
Table Global Sickle Cell Disease Treatments Market Size 2014-2025 (Million US$)
Figure Global Sickle Cell Disease Treatments Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sickle Cell Disease Treatments Market Size by Regions 2014-2025 (Million US$)
Table Global Sickle Cell Disease Treatments Market Size by Regions 2014-2019 (Million US$)
Table Global Sickle Cell Disease Treatments Market Share by Regions 2014-2019
Figure Global Sickle Cell Disease Treatments Market Share by Regions 2014-2019
Figure Global Sickle Cell Disease Treatments Market Share by Regions 2019
Table Market Top Trends
Table Global Sickle Cell Disease Treatments Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sickle Cell Disease Treatments Market Share by Manufacturers (2014-2019)
Figure Global Sickle Cell Disease Treatments Market Share by Manufacturers in 2018
Table Global Sickle Cell Disease Treatments Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sickle Cell Disease Treatments Product/Solution/Service
Table Date of Enter into Sickle Cell Disease Treatments Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table Global Sickle Cell Disease Treatments Market Size Share by Type (2014-2019)
Figure Global Sickle Cell Disease Treatments Market Size Market Share by Type (2014-2019)
Table Global Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table Global Sickle Cell Disease Treatments Market Size Share by Application (2014-2019)
Figure Global Sickle Cell Disease Treatments Market Size Market Share by Application (2014-2019)
Figure Global Sickle Cell Disease Treatments Revenue Market Share by Application in 2018
Figure United States Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table United States Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table United States Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table United States Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table United States Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table United States Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table United States Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Figure Europe Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table Europe Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table Europe Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table Europe Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table Europe Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table Europe Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table Europe Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Figure China Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table China Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table China Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table China Sickle Cell Disease Treatments Market Size by Type (2014-20189) (Million US$)
Table China Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table China Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table China Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Figure Japan Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table Japan Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table Japan Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table Japan Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table Japan Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table Japan Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table Japan Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Figure Southeast Asia Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table Southeast Asia Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table Southeast Asia Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Figure India Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table India Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table India Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table India Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table India Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table India Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table India Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Figure Central & South America Sickle Cell Disease Treatments Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sickle Cell Disease Treatments Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sickle Cell Disease Treatments Market Share (2018-2019)
Table Central & South America Sickle Cell Disease Treatments Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sickle Cell Disease Treatments Market Share by Type (2014-2019)
Table Central & South America Sickle Cell Disease Treatments Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sickle Cell Disease Treatments Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Eli Lilly Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis Company Details
Table Novartis Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Pfizer Recent Development
Table Baxter Company Details
Table Baxter Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Baxter Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Baxter Recent Development
Table Emmaus Life Sciences Company Details
Table Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Emmaus Life Sciences Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Bluebird Bio Recent Development
Table Global Blood Therapeutics Company Details
Table Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Global Blood Therapeutics Recent Development
Table Sangamo Therapeutics Company Details
Table Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2014-2019)(Million US$)
Figure Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2014-2019)
Table Sangamo Therapeutics Recent Development
Table Acceleron Pharma Company Details
Table Arena Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Company Details
Table Global Sickle Cell Disease Treatments Market Size by Regions (Million US$) 2019-2025
Figure Global Sickle Cell Disease Treatments Market Size Share by Regions (2019-2025)
Figure Global Sickle Cell Disease Treatments Market Size Share by Regions in 2025
Figure United States Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Figure China Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Figure India Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sickle Cell Disease Treatments Market Size Forecast (2019-2025)(Million USD)
Table Global Sickle Cell Disease Treatments Market Size by Product (2019-2025) (Million US$)
Figure Global Sickle Cell Disease Treatments Market Size by Product (2019-2025)
Figure Global Sickle Cell Disease Treatments Market Size by Product in 2025
Table Global Sickle Cell Disease Treatments Market Size by Application (2019-2025) (Million US$)
Figure Global Sickle Cell Disease Treatments Market Size by Application (2019-2025)
Figure Global Sickle Cell Disease Treatments Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
鎌状赤血球病治療の世界市場：市場規模・現状・予測 Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents.The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. In 2018, the global Si…- 鎌状赤血球病治療法の世界市場：インサイト・予測 Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape…
- 鎌状赤血球貧血治療法の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 鎌状赤血球貧血治療の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 世界の鎌状赤血球貧血治療法市場：動向・競争分析 Sickle cell anemia is an inherited form of anemia — a condition in which there aren't enough healthy red blood cells to carry adequate oxygen throughout your body.In 2018, the global Sickle Cell Anemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a…